Phendimetrazine Tartrate
Loading...Phendimetrazine Tartrate Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Phendimetrazine tartrate should not be used in combination with other anorectic agents, including prescribed drugs, over-the-counter preparations and herbal products.
In a case-control epidemiological study, the use of anorectic agents, including phendimetrazine tartrate, was associated with an increased risk of developing pulmonary hypertension, a rare, but often fatal disorder. The use of anorectic agents for longer than three months was associated with a 23-fold increase in the risk of developing pulmonary hypertension. Increased risk of pulmonary hypertension with repeated courses of therapy cannot be excluded.
The onset or aggravation of exertional dyspnea, or unexplained symptoms of angina pectoris, syncope, or lower extremity edema suggest the possibility of occurrence of pulmonary hypertension. Under these circumstances, phendimetrazine tartrate should be immediately discontinued, and the patient should be evaluated for the possible presence of pulmonary hypertension.
Valvular heart disease associated with the use of some anorectic agents such as fenfluramine and dexfenfluramine has been reported. Possible contributing factors include use for extended periods of time, higher than recommended dose, and/or use in combination with other anorectic drugs. However, no cases of this valvulopathy have been reported when phendimetrazine tartrate has been used alone.
The potential risk of possible serious adverse effects such as valvular heart disease and pulmonary hypertension should be assessed carefully against the potential benefit of weight loss. Baseline cardiac evaluation should be considered to detect pre-existing valvular heart diseases or pulmonary hypertension prior to initiation of phendimetrazine treatment. Phendimetrazine tartrate is not recommended in patients with known heart murmur or valvular heart disease. Echocardiogram during and after treatment could be useful for detecting any valvular disorders which may occur. To limit unwarranted exposure and risks, treatment with phendimetrazine tartrate should be continued only if the patient has satisfactory weight loss within the first 4 weeks of treatment (i.e., weight loss of at least 4 pounds, or as determined by the physician and patient).
Tolerance to the anorectic effect of phendimetrazine develops within a few weeks. When this occurs, its use should be discontinued; the maximum recommended dose should not be exceeded.
Use of phendimetrazine tartrate within 14 days following the administration of monoamine oxidase inhibitors may result in a hypertensive crisis.
Abrupt cessation of administration following prolonged high dosage results in extreme fatigue and depression. Because of the effect on the central nervous system, phendimetrazine tartrate may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or driving a motor vehicle; the patient should therefore be cautioned accordingly.
Phendimetrazine tartrate is not recommended for patients who used any anorectic agents within the prior year.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Phendimetrazine tartrate is indicated in the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (BMI) of 30 kg/m2 or higher who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone. Below is a chart of Body Mass Index (BMI) based on various heights and weights. BMI is calculated by taking the patient’s weight, in kilograms (kg), divided by the patient’s height, in meters (m), squared. Metric conversions are as follows: pounds ÷ 2.2 = kg; inches x 0.0254 = meters.
| Weight(pounds) | 5’0” | 5’3” | 5’6” | 5’9” | 6’0” | 6’3” |
| 140 | 27 | 25 | 23 | 21 | 19 | 18 |
| 150 | 29 | 27 | 24 | 22 | 20 | 19 |
| 160 | 31 | 28 | 26 | 24 | 22 | 20 |
| 170 | 33 | 30 | 28 | 25 | 23 | 21 |
| 180 | 35 | 32 | 29 | 27 | 25 | 23 |
| 190 | 37 | 34 | 31 | 28 | 26 | 24 |
| 200 | 39 | 36 | 32 | 30 | 27 | 25 |
| 210 | 41 | 37 | 34 | 31 | 29 | 26 |
| 220 | 43 | 39 | 36 | 33 | 30 | 28 |
| 230 | 45 | 41 | 37 | 34 | 31 | 29 |
| 240 | 47 | 43 | 39 | 36 | 33 | 30 |
| 250 | 49 | 44 | 40 | 37 | 34 | 31 |
Phendimetrazine tartrate is indicated for use as monotherapy only.
History
There is currently no drug history available for this drug.
Other Information
Phendimetrazine tartrate, as the dextro isomer, has the chemical name of (2S,3S)-3,4-Dimethyl-2-phenylmorpholine L-(+)- tartrate (1:1).
The structural formula is:
C12H17NO•C4H6O6 M.W. 341.36
Phendimetrazine tartrate is a white, odorless crystalline powder. It is freely soluble in water; sparingly soluble in warm alcohol, insoluble in chloroform, acetone, ether and benzene.
Each white tablet, for oral administration, contains 35 mg of phendimetrazine tartrate. In addition, the following inactive ingredients are present: Colloidal Silicon Dioxide, Lactose Monohydrate, Magnesium Stearate, Microcrystalline Cellulose 102 and Sodium Starch Glycolate. The yellow tablet also contains FD&C Yellow # 5 Aluminum Lake (15-17%). The blue tablet also contains FD&C Blue # 1 Aluminum Lake (11-13%).
Sources
Phendimetrazine Tartrate Manufacturers
-
A-s Medication Solutions Llc
![Phendimetrazine Tartrate Tablet [A-s Medication Solutions Llc]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Phendimetrazine Tartrate | A-s Medication Solutions Llc
Usual Adult Dosage: 1 tablet (35 mg) twice a day or three times a day one hour before meals.
Dosage should be individualized to obtain an adequate response with the lowest effective dosage. In some cases, ½ tablet (17.5 mg) per dose may be adequate. Dosage should not exceed 2 tablets three times a day.
-
A-s Medication Solutions Llc
Phendimetrazine Tartrate | A-s Medication Solutions Llc
Usual Adult Dosage: 1 tablet (35 mg) twice a day or three times a day one hour before meals.
Dosage should be individualized to obtain an adequate response with the lowest effective dosage. In some cases, ½ tablet (17.5 mg) per dose may be adequate. Dosage should not exceed 2 tablets three times a day.
-
A-s Medication Solutions Llc
Phendimetrazine Tartrate | A-s Medication Solutions Llc
Extended-release capsule
Since the product is an extended-release dosage form, limit to one extended-release capsule (105 mg phendimetrazine tartrate) in the morning (30 to 60 minutes before morning meal).
Each extended-release capsule contains 105 mg phendimetrazine tartrate in a Brown/Clear capsule imprinted E 5254.
-
Apotheca, Inc.
Phendimetrazine Tartrate | Apotheca, Inc.
Usual Adult Dose: 1 tablet (35 mg) b.i.d. or t.i.d., one hour before meals.
Dosage should be individualized to obtain an adequate response with the lowest effective dosage. In some cases, 1/2 tablet (17.5 mg) per dose may be adequate. Dosage should not exceed 2 tablets t.i.d.
-
Apotheca, Inc.
Phendimetrazine Tartrate | Apotheca, Inc.
Extended-release capsuleSince the product is an extended-release dosage form, limit to one extended-release capsule (105 mg Phendimetrazine Tartrate) in the morning (30-60 minutes before morning meal).
. -
Physicians Total Care, Inc.
Phendimetrazine Tartrate | Physicians Total Care, Inc.
Usual Adult Dose: 1 tablet (35 mg) b.i.d. or t.i.d., one hour before meals.
Dosage should be individualized to obtain an adequate response with the lowest effective dosage. In some cases, 1/2 tablet (17.5 mg) per dose may be adequate. Dosage should not exceed 2 tablets t.i.d.
-
Bryant Ranch Prepack
Phendimetrazine Tartrate |
-
Rebel Distributors Corp
Phendimetrazine Tartrate | Rebel Distributors Corp
Usual Adult Dose: 1 tablet (35 mg) b.i.d. or t.i.d., one hour before meals.
Dosage should be individualized to obtain an adequate response with the lowest effective dosage. In some cases, 1/2 tablet (17.5 mg) per dose may be adequate. Dosage should not exceed 2 tablets t.i.d.
-
Stat Rx Usa Llc
Phendimetrazine Tartrate | Stat Rx Usa Llc
Usual Adult Dose: 1 tablet (35 mg) b.i.d. or t.i.d., one hour before meals.
Dosage should be individualized to obtain an adequate response with the lowest effective dosage. In some cases 1/2 tablet (17.5 mg) per dose may be adequate. Dosage should not exceed 2 tablets t.i.d.
-
Solco Healthcare Us Llc
Phendimetrazine Tartrate | Solco Healthcare Us Llc
Usual Adult Dose: 1 tablet (35 mg) b.i.d. or t.i.d., one hour before meals.
Dosage should be individualized to obtain an adequate response with the lowest effective dosage. In some cases, 1/2 tablet (17.5 mg) per dose may be adequate. Dosage should not exceed 2 tablets t.i.d.
-
H.j. Harkins Company, Inc.
Phendimetrazine Tartrate | H.j. Harkins Company, Inc.
Usual Adult Dosage: 1 tablet (35 mg) twice a day or three times a day one hour before meals.
Dosage should be individualized to obtain an adequate response with the lowest effective dosage. In some cases, ½ tablet (17.5 mg) per dose may be adequate. Dosage should not exceed 2 tablets three times a day.
-
Eon Labs, Inc.
Phendimetrazine Tartrate | Eon Labs, Inc.
Extended-release capsule
Since the product is an extended-release dosage form, limit to one extended-release capsule (105 mg phendimetrazine tartrate) in the morning (30 to 60 minutes before morning meal).
Each extended-release capsule contains 105 mg phendimetrazine tartrate in a Brown/Clear capsule imprinted E 5254.
-
Life Line Home Care Services, Inc.
Phendimetrazine Tartrate | Life Line Home Care Services, Inc.
Usual Adult Dosage: 1 tablet (35 mg) twice a day or three times a day one hour before meals.
Dosage should be individualized to obtain an adequate response with the lowest effective dosage. In some cases, ½ tablet (17.5 mg) per dose may be adequate. Dosage should not exceed 2 tablets three times a day.
-
Physicians Total Care, Inc.
Phendimetrazine Tartrate | Physicians Total Care, Inc.
Extended-release capsule
Since the product is an extended-release dosage form, limit to one extended-release capsule (105 mg phendimetrazine tartrate) in the morning (30 to 60 minutes before morning meal).
Each extended-release capsule contains 105 mg phendimetrazine tartrate in a Brown/Clear capsule imprinted E 5254.
-
Pd-rx Pharmaceuticals, Inc.
Phendimetrazine Tartrate | Dong Sung Pharm Co., Ltd.
There is currently no dosage information available for this product. We apologize for any inconvenience.
-
Aidarex Pharmaceuticals Llc
Phendimetrazine Tartrate | Aidarex Pharmaceuticals Llc
Usual Adult Dosage: 1 tablet (35 mg) twice a day or three times a day one hour before meals.
Dosage should be individualized to obtain an adequate response with the lowest effective dosage. In some cases, ½ tablet (17.5 mg) per dose may be adequate. Dosage should not exceed 2 tablets three times a day.
-
Bryant Ranch Prepack
Phendimetrazine Tartrate | Bryant Ranch Prepack
Extended-release capsuleSince the product is an extended-release dosage form, limit to one extended-release capsule (105 mg Phendimetrazine Tartrate) in the morning (30-60 minutes before morning meal).
Each extended-release capsule contains 105 mg phendimetrazine tartrate in a Brown/Clear capsule imprinted E 5254.
-
Actavis, Inc.
Phendimetrazine Tartrate | Actavis, Inc.
Usual Adult Dosage: 1 tablet (35 mg) twice a day or three times a day one hour before meals.
Dosage should be individualized to obtain an adequate response with the lowest effective dosage. In some cases, 1/2 tablet (17.5 mg) per dose may be adequate. Dosage should not exceed 2 tablets three times a day.
-
A-s Medication Solutions Llc
Phendimetrazine Tartrate | P & L Development, Llc
do not take more than directed (see overdose warning) adults and children 12 years and over: take 2 caplets at bedtime. Do not take more than 2 caplets of this product in 24 hours. children under 12 years: do not use -
Mikart, Inc.
Phendimetrazine Tartrate | Mikart, Inc.
Usual Adult Dosage: 1 tablet (35 mg) twice a day or three times a day one hour before meals.
Dosage should be individualized to obtain an adequate response with the lowest effective dosage. In some cases, 1/2 tablet (17.5 mg) per dose may be adequate. Dosage should not exceed 2 tablets three times a day.
-
A-s Medication Solutions Llc
Phendimetrazine Tartrate | A-s Medication Solutions Llc
Extended-release capsule
Since the product is an extended-release dosage form, limit to one extended-release capsule (105 mg phendimetrazine tartrate) in the morning (30 to 60 minutes before morning meal).
Each extended-release capsule contains 105 mg phendimetrazine tartrate in a Brown/Clear capsule imprinted E 5254.
-
Preferred Pharmaceuticals, Inc.
Phendimetrazine Tartrate | Preferred Pharmaceuticals, Inc.
Acute overdosage with phendimetrazine tartrate may manifest itself by the following signs and symptoms: unusual restlessness, confusion, belligerence, hallucinations and panic states. Fatigue and depression usually follow the central stimulation. Cardiovascular effects include arrhythmias, hypertension or hypotension and circulatory collapse. Gastrointestinal symptoms include nausea, vomiting, diarrhea and abdominal cramps. Poisoning may result in convulsions, coma and death.
The management of overdosage is largely symptomatic. It includes sedation with a barbiturate. If hypertension is marked, the use of a nitrate or rapid-acting alpha receptor-blocking agent should be considered. Experience with hemodialysis or peritoneal dialysis is inadequate to permit recommendations for its use.
Usual Adult Dose1 tablet (35 mg) b.i.d. or t.i.d., one hour before meals.
Dosage should be individualized to obtain an adequate response with the lowest effective dosage. In some cases 1/2 tablet (17.5 mg) per dose may be adequate. Dosage should not exceed 2 tablets t.i.d.
-
Mikart, Inc.
Phendimetrazine Tartrate | Mikart, Inc.
Usual Adult Dosage: 1 tablet (35 mg) twice a day or three times a day one hour before meals.
Dosage should be individualized to obtain an adequate response with the lowest effective dosage. In some cases, 1/2 tablet (17.5 mg) per dose may be adequate. Dosage should not exceed 2 tablets three times a day.
-
C.o. Truxton, Inc.
Phendimetrazine Tartrate | C.o. Truxton, Inc.
Usual Adult Dosage: 1 tablet (35 mg) twice a day or three times a day one hour before meals.
Dosage should be individualized to obtain an adequate response with the lowest effective dosage. In some cases, 1/2 tablet (17.5 mg) per dose may be adequate. Dosage should not exceed 2 tablets three times a day.
-
C.o. Truxton, Inc.
Phendimetrazine Tartrate | C.o. Truxton, Inc.
Usual Adult Dosage: 1 tablet (35 mg) twice a day or three times a day one hour before meals.
Dosage should be individualized to obtain an adequate response with the lowest effective dosage. In some cases, 1/2 tablet (17.5 mg) per dose may be adequate. Dosage should not exceed 2 tablets three times a day.
-
C.o. Truxton, Inc.
Phendimetrazine Tartrate | C.o. Truxton, Inc.
Usual Adult Dosage: 1 tablet (35 mg) twice a day or three times a day one hour before meals.
Dosage should be individualized to obtain an adequate response with the lowest effective dosage. In some cases, 1/2 tablet (17.5 mg) per dose may be adequate. Dosage should not exceed 2 tablets three times a day.
-
Aidarex Pharmaceuticals Llc
Phendimetrazine Tartrate | Aidarex Pharmaceuticals Llc
Extended-release capsule
Since the product is an extended-release dosage form, limit to one extended-release capsule (105 mg phendimetrazine tartrate) in the morning (30 to 60 minutes before morning meal).
Each extended-release capsule contains 105 mg phendimetrazine tartrate in a Brown/Clear capsule imprinted E 5254.
-
Pd-rx Pharmaceuticals, Inc.
Phendimetrazine Tartrate | Pd-rx Pharmaceuticals, Inc.
Usual Adult Dosage: 1 tablet (35 mg) twice a day or three times a day one hour before meals.
Dosage should be individualized to obtain an adequate response with the lowest effective dosage. In some cases, ½ tablet (17.5 mg) per dose may be adequate. Dosage should not exceed 2 tablets three times a day.
-
Elite Laboratories, Inc
Phendimetrazine Tartrate | Elite Laboratories, Inc
Usual Adult Dosage: 1 tablet (35 mg) twice a day or three times a day one hour before meals.
Dosage should be individualized to obtain an adequate response with the lowest effective dosage. In some cases, 1/2 tablet (17.5 mg) per dose may be adequate. Dosage should not exceed 2 tablets three times a day.
-
Eon Labs, Inc.
Phendimetrazine Tartrate | Eon Labs, Inc.
Acute overdosage with phendimetrazine tartrate may manifest itself by the following signs and symptoms: unusual restlessness, confusion, belligerence, hallucinations and panic states. Fatigue and depression usually follow the central stimulation. Cardiovascular effects include arrhythmias, hypertension or hypotension and circulatory collapse. Gastrointestinal symptoms include nausea, vomiting, diarrhea and abdominal cramps. Poisoning may result in convulsions, coma and death.
The management of overdosage is largely symptomatic. It includes sedation with a barbiturate. If hypertension is marked, the use of a nitrate or rapid-acting alpha receptor-blocking agent should be considered. Experience with hemodialysis or peritoneal dialysis is inadequate to permit recommendations for its use.
Usual Adult Dose1 tablet (35 mg) b.i.d. or t.i.d., one hour before meals.
Dosage should be individualized to obtain an adequate response with the lowest effective dosage. In some cases 1/2 tablet (17.5 mg) per dose may be adequate. Dosage should not exceed 2 tablets t.i.d.
-
A-s Medication Solutions Llc
Phendimetrazine Tartrate | A-s Medication Solutions Llc
Usual Adult Dosage: 1 tablet (35 mg) twice a day or three times a day one hour before meals.
Dosage should be individualized to obtain an adequate response with the lowest effective dosage. In some cases, ½ tablet (17.5 mg) per dose may be adequate. Dosage should not exceed 2 tablets three times a day.
![Phendimetrazine Tartrate Tablet [A-s Medication Solutions Llc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=483850a2-eb90-4d41-9fdf-4683478d528b&name=3e594fab-figure-01.jpg)
![Phendimetrazine Tartrate Capsule, Extended Release [A-s Medication Solutions Llc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=1aa3fdcb-b107-406c-bbe1-78da87852d77&name=50090-0338-1.jpg)
![Phendimetrazine Tartrate Tablet [Apotheca, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=b045cbd6-68ca-4a9b-a6e6-625d736a079b&name=phen35-02.jpg)
![Phendimetrazine Tartrate Capsule [Apotheca, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=5803a3c0-7434-40f3-af5e-cf33b3e2c448&name=phen105-02.jpg)
![Phendimetrazine Tartrate Tablet [Physicians Total Care, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=e9130f1a-06c0-4d84-b185-de44e5ba345b&name=packagelabel.jpg)
![Phendimetrazine Tartrate Tablet [Bryant Ranch Prepack]](http://recallguide.cwdevelopsp.com/wp-content/themes/recallguide/assets/img/drug-image-placeholder.jpg)
![Phendimetrazine Tartrate Tablet [Rebel Distributors Corp]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=f31c768e-4156-4ebe-8dce-763bf940ab1b&name=f31c768e-4156-4ebe-8dce-763bf940ab1b-01.jpg)
![Phendimetrazine Tartrate Tablet [Stat Rx Usa Llc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=79719e0a-587f-4f60-a8e5-a28edf5bd7da&name=PHENDIMETRAZINE35MGLAB642.jpg)
![Phendimetrazine Tartrate Tablet [Solco Healthcare Us Llc ]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=59f1344d-5643-4492-acfd-0fa86b1a89d2&name=phe01-0000-02.jpg)
![Phendimetrazine Tartrate Tablet [H.j. Harkins Company, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=49b13acc-c7a9-4f7c-bcc2-2c73fcedab52&name=3e594fab-figure-01.jpg)
![Phendimetrazine Tartrate Capsule, Extended Release [Eon Labs, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=fc4a052c-29ff-428b-bdf1-bb079f10c0bc&name=be93c2d6-0c89-4171-a881-29feeeb949e6-03.jpg)
![Phendimetrazine Tartrate Tablet [Life Line Home Care Services, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=3cdcbdf5-ee90-457b-a026-59206ea8e978&name=PHENDIMETRAZINE35MG.jpg)
![Phendimetrazine Tartrate Capsule, Extended Release [Physicians Total Care, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=67e2f269-b73d-4ff5-8177-ecf79536648c&name=3071.jpg)
![Phendimetrazine Tartrate Capsule, Extended Release [Pd-rx Pharmaceuticals, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=a281c1ce-f024-47fb-87ab-6298c110fd73&name=a.c.careSunProtection-prod.jpg)
![Phendimetrazine Tartrate Tablet [Aidarex Pharmaceuticals Llc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=2998fe3c-5a71-421a-9bb3-dc98104c5db3&name=phendimetrazine-tartrate-3.jpg)
![Phendimetrazine Tartrate Capsule, Extended Release [Bryant Ranch Prepack]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=675e6738-a39c-209d-0f05-aa120f0a0695&name=label1datamaxfda339.jpg)
![Phendimetrazine Tartrate Tablet [Actavis, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=d11411e2-ccfa-49b0-8470-5682053cfb1b&name=e1f208ca-7f3d-496d-ada7-7d936ea43807-02.jpg)
![Phendimetrazine Tartrate Tablet [A-s Medication Solutions Llc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=3957f9f0-b10c-4a76-a6ad-79a72896a543&name=extra-strength-pain-reliever-pm-wellness-basics-1.jpg)
![Phendimetrazine Tartrate Tablet [Mikart, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=a3becb48-a057-4d3f-b50f-bae21c9a1af2&name=a3becb48-a057-4d3f-b50f-bae21c9a1af2-02.jpg)
![Phendimetrazine Tartrate Capsule, Extended Release [A-s Medication Solutions Llc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=0e188d37-adea-40d7-a7cb-1344a80d4260&name=2198-0.jpg)
![Phendimetrazine Tartrate Tablet [Preferred Pharmaceuticals, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=63a6b1fb-5cdd-4442-96be-fb19950605a7&name=9a5b9ba2-fe9b-495a-80a2-b8a317ad4538-02.jpg)
![Phendimetrazine Tartrate Tablet [Mikart, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=706e7a68-9d0a-48d2-88f6-9d55bbacd83f&name=b72f962a-379d-419b-9b07-5e1e00893cc9-02.jpg)
![Phendimetrazine Tartrate Tablet [C.o. Truxton, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=3a4e7fdb-959c-45c5-a847-b12615f06201&name=cd472295-183d-400a-89eb-77d03c943c94-02.jpg)
![Phendimetrazine Tartrate Tablet [C.o. Truxton, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=702670ca-02df-44dc-b8a0-850a10a98ef5&name=d34a4bba-1c0c-41dc-9c54-36fbb6960339-02.jpg)
![Phendimetrazine Tartrate Tablet [C.o. Truxton, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=b06b1320-d88d-4fd3-bf08-613d44d26504&name=b06b1320-d88d-4fd3-bf08-613d44d26504-02.jpg)
![Phendimetrazine Tartrate Capsule, Extended Release [Aidarex Pharmaceuticals Llc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=79c40fc0-bfd0-4a35-bb3f-5193a9930f7c&name=phendimetrazine-tart-er-105mg-cap-for-epic-3.jpg)
![Phendimetrazine Tartrate Tablet [Pd-rx Pharmaceuticals, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=467ae7d7-e342-423b-be89-5d38c1abf3c9&name=3e594fab-figure-01.jpg)
![Phendimetrazine Tartrate Tablet [Elite Laboratories, Inc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=42ecacde-6859-47c6-ba44-13fb4f3b5448&name=42ecacde-6859-47c6-ba44-13fb4f3b5448-02.jpg)
![Phendimetrazine Tartrate Tablet [Eon Labs, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=8681ce6d-6a19-4bcf-984e-88bb6eaed559&name=4831ce38-03bc-447e-8435-02eaf8696157-02.jpg)
![Phendimetrazine Tartrate Tablet [A-s Medication Solutions Llc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=a4969a42-d71e-4615-8e41-f65738ef311a&name=2668-5.jpg)
Login To Your Free Account